Medycyna Kliniczna

Warsaw, Masovian Voivodeship 00874

0 studies enrolling now · 4 studies all time

What they study most

Plaque Psoriasis, Rheumatoid Arthritis, Systemic Lupus Erythematosus

Studies at this site

• A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis — Completed
• A Study to Investigate ABP 654 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis — Completed
• A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE) — Stopped early
• A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE-BRAVE II) — Completed